L-Carnosine and Reduced Extrapyramidal Symptoms

Doses used in studies

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

Safety in these studies

Overall tolerabilityNo significant difference
Frequency of other side effects was not significantly different between the two groups.
from: L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients wit
extrapyramidal symptomsNo significant difference
Both groups demonstrated a constant ESRS score during the trial course.
from: L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients wit

1 of 1 paper

L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.